EFFECTS OF ACETATE ON LEFT-VENTRICULAR FUNCTION IN HEMODIALYSIS-PATIENTS

被引:3
作者
WIZEMANN, V
SOETANTO, R
THORMANN, J
LUBBECKE, F
KRAMER, W
机构
[1] KERKHOFF KLIN,BAD NAUHEIM,GERMANY
[2] DEPT INTERNAL MED,GIESSEN,GERMANY
[3] KREISKRANKENHAUS WETZLAR,WETZLAR,GERMANY
来源
NEPHRON | 1993年 / 64卷 / 01期
关键词
ACETATE; DIALYSIS; LEFT VENTRICULAR FUNCTION;
D O I
10.1159/000187286
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Two approaches were chosen to assess the controversially debated influence of acetate on the heart in dialysis patients: (1) To separate acetate effects from influences of dialysis, acetate was infused in 12 chronic dialysis patients with normal systolic function on a dialysis-free day, and left ventricular (LV) function was assessed by LV pressure/volume loops. Hyperacetatemia (3-5 mmol/l) resulted in a decrease in LV preload (LV end-diastolic pressure decreased from 16 +/- 3 to 10 +/- 4 mm Hg, p < 0.01) but had no influence on LV contractility. (2) In 8 dialysis patients without cardiac disease, isovolemic acetate or bicarbonate dialysis was performed. During both procedures, there were comparable changes in serum electrolytes as well as in echocardiographic parameters. LV contractility measured by velocity of circumferential fiber shortening increased during acetate and bicarbonate dialysis (1.47 +/- 0.22 to 1.77 +/- 0.29, p < 0.01; 1.47 +/- 0.21 to 1.70 +/- 0.22 circ/s, p < 0.01. It is concluded that mild hyperacetatemia does not influence LV contractility and that dialysis-induced changes in serum electrolytes are responsible for the increase in LV contractility during dialysis. However, the pronounced acetate effect on LV preload implies considerable therapeutic implications.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 29 条
[1]  
ALZAWA Y, 1977, CLIN NEPHROL, V8, P477
[2]  
ARTIS AK, 1989, KIDNEY INT S1, V35, P328
[3]   ASSESSMENT OF THE CARDIAC EFFECTS OF HEMODIALYSIS WITH SYSTOLIC-TIME INTERVALS AND ECHOCARDIOGRAPHY [J].
BORNSTEIN, A ;
GAASCH, WH ;
HARRINGTON, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (02) :332-335
[4]  
BRANGER B, 1984, CONTRIB NEPHROL, V41, P383
[5]  
CHAZAN JA, 1987, DIALYSIS TRANSPLANT, V16, P447
[6]   LESS DIALYSIS-INDUCED MORBIDITY AND VASCULAR INSTABILITY WITH BICARBONATE IN DIALYSATE [J].
GRAEFE, U ;
MILUTINOVICH, J ;
FOLLETTE, WC ;
VIZZO, JE ;
BABB, AL ;
SCRIBNER, BH .
ANNALS OF INTERNAL MEDICINE, 1978, 88 (03) :332-336
[7]  
GROSSMAN W, 1980, CARDIAC CATHETERIZAT, P87
[8]  
HEINRICH WL, 1984, NEW ENGL J MED, V310, P19
[9]  
ISEKI K, 1980, CLIN NEPHROL, V14, P294
[10]  
KIRKENDOL PL, 1977, T AM SOC ART INT ORG, V23, P399